Topiramate Capsule
Product Images NDC 59651-452

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 59651-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Topiramate Fig1)

Fig1 (Topiramate Fig1)
A Kaplan-Meier graph depicting cumulative rates for time to first seizure over 500 days. The graph compares two dosing groups of Topiramate: 50 mg/day (solid line) and 400 mg/day (dotted line), with cumulative seizure rates on the y-axis and time in days on the x-axis. A statistical significance p-value of 0.0002 is noted on the chart.*
FDA Label Image

Fig2 (Topiramate Fig2)

Fig2 (Topiramate Fig2)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine days between placebo and different doses of topiramate (50 mg/day, 100 mg/day, 200 mg/day) in two clinical studies (Study 11 and Study 12) for adults and adolescents. The vertical axis shows the change in migraine days, while bars represent results for each treatment group with statistical significance indicated by asterisks.*
FDA Label Image

Package Label-principal Display Panel (15 mg (60 Capsules Bottle))

Package Label-principal Display Panel (15 mg (60 Capsules Bottle))
Topiramate Capsules USP 15 mg oral capsules carton label from Aurobindo Pharma Limited. The label indicates 60 capsules per container, with instructions for pharmacists to dispense the Medication Guide separately. The capsules are described as white to off-white pellets in a white opaque capsule imprinted with "15 mg" and "TPT". The label includes storage instructions, distributor address in East Windsor, NJ, and country of manufacture is India.*
FDA Label Image

Package Label-principal Display Panel (25 mg (60 Capsules Bottle))

Package Label-principal Display Panel (25 mg (60 Capsules Bottle))
Label for Topiramate Capsules USP 25 mg by Aurobindo Pharma Limited. The oral capsule packaging contains 60 capsules. The label includes dosing details, storage instructions, distributor information (Aurobindo Pharma USA, Inc.), barcode, and a medication guide notice for pharmacists to dispense separately.*
FDA Label Image

Str (Topiramate Str)

Str (Topiramate Str)
Chemical structure diagram of topiramate, showing its detailed molecular framework including carbon, oxygen, sulfur, nitrogen, and hydrogen atoms in the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.